Table 5.
Parameters | 2019 (N = 828) | 2020 (N = 710) | χ2/t value | p value |
---|---|---|---|---|
Gender | 0.123 | 0.726 | ||
Male | 518 (62.6) | 438 (61.7) | ||
Female | 310 (37.4) | 272 (38.3) | ||
Age(years)a | 0.706 | 0.401 | ||
< 70 | 673 (81.3) | 565 (79.6) | ||
≥ 70 | 155 (18.7) | 145 (20.4) | ||
Area of origin | 0.107 | 0.743 | ||
Local | 212 (25.6) | 187 (26.3) | ||
Migrant | 616 (74.4) | 523 (73.7) | ||
CRC location | 2.336 | 0.311 | ||
Right colon | 181 (21.9) | 166 (23.4) | ||
Left colon | 276 (33.3) | 211 (29.7) | ||
Rectum | 371 (44.8) | 333 (46.9) | ||
Neoadjuvant chemotherapy | 2.596 | 0.124 | ||
Received | 110 (13.3) | 115 (16.2) | ||
Neoadjuvant radiotherapy for rectal cancer | 4.451 | 0.039 | ||
Received | 65 (17.5) | 79 (23.9) | ||
Operative methods | 15.333 | < 0.001 | ||
Laparoscopic | 327 (39.5) | 351 (49.4) | ||
Laparotomy | 501 (60.5) | 359 (50.6) | ||
Transfusion | 0.002 | 0.963 | ||
Received | 52 (6.3) | 45 (6.3) | ||
Enterostomy | 5.163 | 0.023 | ||
Received | 109 (13.2) | 123 (17.3) | ||
Major complication | 1.121 | 0.290 | ||
Occurrence | 42 (5.1) | 28 (3.9) | ||
Preoperative waiting (d.)a | 3.8 ± 2.8 | 4.8 ± 3.0 | − 6.817 | < 0.001 |
Postoperative stay (d.)a | 7.2 ± 2.8 | 8.4 ± 3.1 | − 7.945 | < 0.001 |
Hospital stay (d.)a | 11.0 ± 4.0 | 13.2 ± 4.5 | − 10.298 | < 0.001 |
CRC colorectal cancer, d. days
aThese data are presented as mean ± standard deviation; other values are presented as number of patients followed by percentage in parentheses